banner
Reference Listed Drugs
Simulect 20mg Basiliximab For Injection Reference Listed Drug

Simulect 20mg Basiliximab For Injection Reference Listed Drug

Simulect is used to prevent early acute organ rejection after kidney transplantation. For R&D purposes only.

Product Details

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

 

Generic name Basiliximab for Injection
Trade name Simulect
Specification 20mg/vial
Main ingredients Basiliximab
Appearance This product is white freeze-dried material.
MA Holder Novartis Pharma Schweiz AG
Manufacturer Novartis Pharma Stein AG

 

 

 

Indications:

Simulect is used to prevent early acute organ rejection after kidney transplantation.
This product is usually used in combination with cyclosporine and corticosteroid based immunosuppressant regimens (adults and children) or long-term cyclosporine, corticosteroid, and azathioprine/mexophenolate based immunosuppressant regimens (adults only).

 

 

Simulect

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

Hot Tags: Simulect 20mg Basiliximab For Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Olanzapine Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Agomelatine Tablets, Alfacalcidol Soft Capsules, Reference Listed Drugs, AdapaleneGel

Send Inquiry
Verification Code: